CMEA VENTURES VII (PARALLEL) LP
Insider CIK 1405972 · ARDX 10% owner · ASPX 10% owner · NEOS 10% owner · MNLO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNLO Menlo Therapeutics Inc. | S Sale | 2018-07-24 | 2018-07-26 | 487,500 | $7.65 | $3.73M | 1,907,568 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | S Sale | 2018-07-24 | 2018-07-26 | 12,500 | $7.65 | $95.6K | 48,910 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | J Other | 2018-03-02 | 2018-07-26 | 152,062 | — | $0 | 152,062 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 179 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 6,971 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 2,292,320 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 58,777 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 343,310 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 21,789 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 3,263 | — | $0 | 61,410 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 2,584 | — | $0 | 1,418,005 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 127,269 | — | $0 | 2,395,068 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 21,789 | — | $0 | 58,147 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 849,794 | — | $0 | 2,267,799 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 66 | — | $0 | 36,358 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-20 | 2016-04-20 | 8,327 | $9.88 | $82.3K | 1,559,995 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-20 | 2016-04-20 | 213 | $9.88 | $2.1K | 39,998 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-19 | 2016-04-20 | 182 | $10.03 | $1.8K | 40,211 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-19 | 2016-04-20 | 7,097 | $10.03 | $71.2K | 1,568,322 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-18 | 2016-04-20 | 114 | $10.10 | $1.2K | 40,393 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-18 | 2016-04-20 | 4,434 | $10.10 | $44.8K | 1,575,419 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 7,020 | $10.32 | $72.4K | 1,579,853 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 275 | $10.13 | $2.8K | 40,687 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 180 | $10.32 | $1.9K | 40,507 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 10,735 | $10.13 | $108.7K | 1,586,873 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 325 | $10.32 | $3.4K | 40,962 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 352 | $10.27 | $3.6K | 41,287 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 12,675 | $10.32 | $130.8K | 1,597,608 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 13,714 | $10.27 | $140.8K | 1,610,283 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-13 | 2016-04-15 | 317 | $10.16 | $3.2K | 41,639 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-13 | 2016-04-15 | 12,375 | $10.16 | $125.7K | 1,623,997 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2015-12-15 | 2015-12-17 | 7,500 | — | $0 | 63,490 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2015-12-15 | 2015-12-17 | 292,500 | — | $0 | 2,476,216 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 10,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 41,700 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 25,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 390,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 1,626,294 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 975,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 17,374 | — | $0 | 1,274,162 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 406,250 | — | $0 | 406,250 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 677,622 | — | $0 | 1,083,872 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 4,166 | — | $0 | 1,278,328 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 10,416 | — | $0 | 1,256,788 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 162,500 | — | $0 | 1,246,372 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise deriv | 2015-07-27 | 2015-07-28 | 10,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise deriv | 2015-07-27 | 2015-07-28 | 390,000 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2015-04-08 | 2015-04-10 | 390,000 | — | $0 | 2,768,716 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2015-04-08 | 2015-04-10 | 10,000 | — | $0 | 70,990 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2015-04-02 | 2015-04-06 | 1 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | J Other deriv | 2015-04-02 | 2015-04-06 | 1 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2015-04-02 | 2015-04-06 | 1 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | J Other deriv | 2015-04-02 | 2015-04-06 | 1 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2015-04-02 | 2015-04-06 | 292,500 | $29.79 | $8.71M | 2,478,021 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2015-04-02 | 2015-04-06 | 7,500 | $29.79 | $223.4K | 63,589 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | J Other | 2015-02-24 | 2015-02-26 | 5,000 | — | $0 | 71,089 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | J Other | 2015-02-24 | 2015-02-26 | 195,000 | — | $0 | 2,770,521 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-13 | 2015-02-17 | 1,047 | $62.98 | $65.9K | 76,089 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-13 | 2015-02-17 | 40,786 | $62.98 | $2.57M | 2,965,521 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-12 | 2015-02-17 | 66,138 | $62.96 | $4.16M | 3,018,982 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-12 | 2015-02-17 | 1,696 | $62.96 | $106.8K | 77,461 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-12 | 2015-02-17 | 325 | $64.00 | $20.8K | 77,136 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-12 | 2015-02-17 | 12,675 | $64.00 | $811.2K | 3,006,307 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-11 | 2015-02-11 | 51,773 | $61.84 | $3.20M | 3,112,120 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-11 | 2015-02-11 | 1,327 | $61.84 | $82.1K | 79,157 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-11 | 2015-02-17 | 1,327 | $61.84 | $82.1K | 79,157 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-11 | 2015-02-17 | 51,773 | $61.84 | $3.20M | 3,085,120 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-10 | 2015-02-11 | 530 | $60.05 | $31.8K | 80,484 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-10 | 2015-02-11 | 20,670 | $60.05 | $1.24M | 3,163,893 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-10 | 2015-02-17 | 20,670 | $60.05 | $1.24M | 3,136,893 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-09 | 2015-02-11 | 9,608 | $59.00 | $566.9K | 3,157,563 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-09 | 2015-02-11 | 246 | $59.00 | $14.5K | 81,014 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-06 | 2015-02-06 | 29,522 | $59.48 | $1.76M | 3,167,171 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-06 | 2015-02-06 | 757 | $59.48 | $45.0K | 81,260 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-05 | 2015-02-06 | 12,578 | $59.51 | $748.5K | 3,196,693 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-05 | 2015-02-06 | 322 | $59.51 | $19.2K | 82,017 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-04 | 2015-02-06 | 1,250 | $59.30 | $74.1K | 82,339 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-02-04 | 2015-02-06 | 48,750 | $59.30 | $2.89M | 3,209,271 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2015-01-30 | 2015-02-03 | 165,750 | $27.37 | $4.54M | 3,158,716 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2015-01-30 | 2015-02-03 | 4,250 | $27.37 | $116.3K | 80,990 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2015-01-08 | 2015-02-17 | 41,282 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2015-01-08 | 2015-02-17 | 1,058 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2015-01-08 | 2015-01-12 | 7,500 | $24.25 | $181.9K | 85,240 | SEC↗ |
| ARDX ARDELYX, INC. | S Sale | 2015-01-08 | 2015-01-12 | 292,500 | $24.25 | $7.09M | 3,324,466 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2015-01-08 | 2015-02-17 | 41,282 | $3.88 | $160.2K | 3,261,281 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-01-08 | 2015-02-17 | 3,260 | $49.13 | $160.2K | 3,258,021 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-01-08 | 2015-02-17 | 84 | $49.13 | $4.1K | 83,589 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2015-01-08 | 2015-02-17 | 1,058 | $3.88 | $4.1K | 83,673 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-30 | 2015-01-02 | 10,000 | — | $0 | 92,740 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2014-12-30 | 2015-01-02 | 390,000 | — | $0 | 3,616,966 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-12-18 | 2014-12-22 | 190,125 | $50.14 | $9.53M | 3,517,374 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | J Other | 2014-12-18 | 2014-12-22 | 7,625 | — | $0 | 82,615 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-12-18 | 2014-12-22 | 4,875 | $50.14 | $244.4K | 90,240 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | J Other | 2014-12-18 | 2014-12-22 | 297,375 | — | $0 | 3,219,999 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-11-10 | 2014-11-12 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-11-10 | 2014-11-12 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-11-10 | 2014-11-12 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-11-10 | 2014-11-12 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-11-10 | 2014-12-01 | 1 | $137198.27 | $137.2K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-11-10 | 2014-12-01 | 1 | $137198.27 | $137.2K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-11-10 | 2014-12-01 | 1 | $137198.27 | $137.2K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-11-10 | 2014-12-01 | 1 | $137198.27 | $137.2K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-30 | 2014-10-31 | 197 | $27.33 | $5.4K | 95,115 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-30 | 2014-10-31 | 7,633 | $27.33 | $208.6K | 3,707,499 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-29 | 2014-10-31 | 10,891 | $27.02 | $294.3K | 3,715,132 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-29 | 2014-10-31 | 279 | $27.02 | $7.5K | 95,312 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-28 | 2014-10-29 | 275 | $26.99 | $7.4K | 95,591 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-28 | 2014-10-29 | 10,725 | $26.99 | $289.5K | 3,726,023 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-27 | 2014-10-29 | 87 | $27.11 | $2.4K | 95,866 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-27 | 2014-10-29 | 3,413 | $27.11 | $92.5K | 3,736,748 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-24 | 2014-10-27 | 272 | $27.09 | $7.4K | 95,953 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-24 | 2014-10-27 | 10,628 | $27.09 | $287.9K | 3,740,161 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-23 | 2014-10-27 | 5,460 | $26.74 | $146.0K | 3,750,789 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-23 | 2014-10-27 | 140 | $26.74 | $3.7K | 96,225 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-10-06 | 2014-10-08 | 1,074 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-10-06 | 2014-10-08 | 41,892 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-10-06 | 2014-10-15 | 1,074 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-10-06 | 2014-10-15 | 41,892 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-06 | 2014-10-08 | 6,931 | $23.45 | $162.5K | 3,781,210 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-10-06 | 2014-10-08 | 1,074 | $3.88 | $4.2K | 104,682 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-06 | 2014-10-08 | 178 | $23.45 | $4.2K | 104,504 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-10-06 | 2014-10-08 | 41,892 | $3.88 | $162.5K | 3,788,141 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-06 | 2014-10-15 | 178 | $23.45 | $4.2K | 96,365 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-10-06 | 2014-10-15 | 1,074 | $3.88 | $4.2K | 96,543 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-10-06 | 2014-10-15 | 6,931 | $23.45 | $162.5K | 3,756,249 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-10-06 | 2014-10-15 | 41,892 | $3.88 | $162.5K | 3,763,180 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-09-09 | 2014-09-11 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-09-09 | 2014-09-11 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-09-09 | 2014-09-11 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-09-09 | 2014-09-11 | 1 | — | $0 | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-09-09 | 2014-09-30 | 1 | $288448.54 | $288.4K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy deriv | 2014-09-09 | 2014-09-30 | 1 | $288448.54 | $288.4K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-09-09 | 2014-09-30 | 1 | $288448.54 | $288.4K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale deriv | 2014-09-09 | 2014-09-30 | 1 | $288448.54 | $288.4K | 1 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-05 | 2014-09-08 | 222 | $23.50 | $5.2K | 95,469 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-05 | 2014-09-08 | 8,678 | $23.50 | $203.9K | 3,721,288 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-04 | 2014-09-08 | 16,283 | $24.05 | $391.6K | 3,729,966 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-04 | 2014-09-08 | 417 | $24.05 | $10.0K | 95,691 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-03 | 2014-09-04 | 12,188 | $23.09 | $281.4K | 3,700,396 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-03 | 2014-09-04 | 312 | $23.09 | $7.2K | 94,933 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-03 | 2014-09-09 | 312 | $23.09 | $7.2K | 96,108 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-03 | 2014-09-09 | 12,188 | $23.09 | $281.4K | 3,746,249 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-02 | 2014-09-04 | 9,945 | $23.07 | $229.4K | 3,712,584 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-02 | 2014-09-04 | 255 | $23.07 | $5.9K | 95,245 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-02 | 2014-09-09 | 9,945 | $23.07 | $229.4K | 3,758,437 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-09-02 | 2014-09-09 | 255 | $23.07 | $5.9K | 96,420 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-29 | 2014-09-03 | 217 | $22.59 | $4.9K | 95,500 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-29 | 2014-09-03 | 8,483 | $22.59 | $191.6K | 3,722,529 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-29 | 2014-09-09 | 8,483 | $22.59 | $191.6K | 3,768,382 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-29 | 2014-09-09 | 217 | $22.59 | $4.9K | 96,675 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-28 | 2014-08-29 | 305 | $22.24 | $6.8K | 95,717 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-28 | 2014-08-29 | 11,895 | $22.24 | $264.5K | 3,731,012 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-28 | 2014-09-09 | 305 | $22.24 | $6.8K | 96,892 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-28 | 2014-09-09 | 11,895 | $22.24 | $264.5K | 3,776,865 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-27 | 2014-08-29 | 435 | $21.88 | $9.5K | 96,022 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-27 | 2014-08-29 | 16,965 | $21.88 | $371.2K | 3,742,907 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-27 | 2014-09-09 | 435 | $21.88 | $9.5K | 97,197 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-27 | 2014-09-09 | 16,965 | $21.88 | $371.2K | 3,788,760 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-26 | 2014-08-28 | 157 | $21.35 | $3.4K | 96,457 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-26 | 2014-08-28 | 6,143 | $21.35 | $131.2K | 3,759,872 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-26 | 2014-09-09 | 157 | $21.35 | $3.4K | 97,632 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-26 | 2014-09-09 | 6,143 | $21.35 | $131.2K | 3,805,725 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-25 | 2014-08-27 | 5,265 | $20.81 | $109.6K | 3,766,015 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-25 | 2014-08-27 | 135 | $20.81 | $2.8K | 96,614 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-25 | 2014-09-09 | 135 | $20.81 | $2.8K | 97,789 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-25 | 2014-09-09 | 5,265 | $20.81 | $109.6K | 3,811,868 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-22 | 2014-08-26 | 1,658 | $20.56 | $34.1K | 3,771,280 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-22 | 2014-08-26 | 42 | $20.56 | $864 | 96,749 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-22 | 2014-09-09 | 42 | $20.56 | $864 | 97,924 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-08-22 | 2014-09-09 | 1,658 | $20.56 | $34.1K | 3,817,133 | SEC↗ |
| ARDX ARDELYX, INC. | X Exercise deriv | 2014-06-24 | 2014-06-26 | 43,970 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | X Exercise deriv | 2014-06-24 | 2014-06-26 | 3,382 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | X Exercise deriv | 2014-06-24 | 2014-06-26 | 1,127 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | X Exercise deriv | 2014-06-24 | 2014-06-26 | 175,882 | — | $0 | 2,841,598 | SEC↗ |
| ARDX ARDELYX, INC. | X Exercise deriv | 2014-06-24 | 2014-06-26 | 4,479 | — | $0 | 72,860 | SEC↗ |
| ARDX ARDELYX, INC. | X Exercise deriv | 2014-06-24 | 2014-06-26 | 131,912 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | J Other deriv | 2014-06-24 | 2014-06-26 | 30 | — | $0 | 72,830 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 2,840,466 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 72,830 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 857,595 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 21,989 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | J Other deriv | 2014-06-24 | 2014-06-26 | 1,132 | — | $0 | 2,840,466 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 72,830 | — | $0 | 72,830 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 2,840,466 | — | $0 | 2,840,466 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2014-06-24 | 2014-06-26 | 7,921 | $14.00 | $110.9K | 102,740 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 21,989 | — | $0 | 94,819 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2014-06-24 | 2014-06-26 | 308,905 | $14.00 | $4.32M | 4,006,966 | SEC↗ |
| ARDX ARDELYX, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 857,595 | — | $0 | 3,698,061 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-05-16 | 2014-09-08 | 1,175 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-05-16 | 2014-09-08 | 45,853 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-05-16 | 2014-09-08 | 45,853 | $3.88 | $177.9K | 3,818,791 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-05-16 | 2014-09-08 | 1,175 | $3.88 | $4.6K | 97,966 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 1,397,873 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 42,340 | — | $0 | 42,340 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 190,535 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 42,966 | — | $0 | 42,966 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 193,348 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 47,028 | — | $0 | 47,028 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 211,629 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 545,243 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 8,510,898 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 5,394,437 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 1,635,551 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 64,449 | — | $0 | 64,449 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 121,165 | — | $0 | 121,165 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 290,022 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-12 | 102,873 | $12.00 | $1.23M | 3,772,938 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-12 | 2,688 | $12.00 | $32.3K | 96,796 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-12 | 94,103 | — | $0 | 94,103 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-12 | 3,670,065 | — | $0 | 3,670,065 | SEC↗ |